Salmonella-induced pericarditis
DOI:
https://doi.org/10.3855/jidc.20219Keywords:
Pericardial fluid culture, pericarditis, Salmonella, salmonellosisAbstract
Introduction: Salmonella-induced pericarditis (SIP) is a rare complication of Salmonella infection, with only 30 cases reported to date, and a mortality rate of 14.8%. It is mostly associated with immunosuppression and can result in complications such as pericardial effusion, cardiac tamponade, and myopericarditis.
Case Presentation: A 58-year-old man complained of chest pain, cold sweats, shortness of breath, cough, and a history of fever. Physical and supporting examinations including echocardiography and pericardial fluid culture were positive for Salmonella based on VITEK 2 Biomerieux. Based on antibiotic sensitivity testing for therapy selection, the patient received 2 grams of ceftriaxone via intravenous (IV) every 24 hours which was then maximized to 2 grams every 12 hours. Outpatient management was planned after confirming the amount of pericardial fluid, last culture results, and clinical improvement.
Discussion: SIP is very rare. These infections are caused by direct spread from intrathoracic foci or hematogenous spread from other sites of infection, including cross-reactivity of infectious antigens with the body`s antigens, and/or the presence of infection stimulating host immune reactions. Antimicrobials such as fluoroquinolones and third-generation cephalosporins can be given for 4-6 weeks, especially in immunocompromised individuals or those with spread to extra-intestinal sites.
Conclusions: SIP in adult patients with comorbidities and immunocompromised are associated with high morbidity and mortality. Early diagnosis, rational antibiotic therapy, and appropriate surgery provide good prognosis for patients.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 I Wayan Suranadi, I Komang Adnyana, Ni Made Adi Tarini

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).